JP2013505251A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505251A5
JP2013505251A5 JP2012529897A JP2012529897A JP2013505251A5 JP 2013505251 A5 JP2013505251 A5 JP 2013505251A5 JP 2012529897 A JP2012529897 A JP 2012529897A JP 2012529897 A JP2012529897 A JP 2012529897A JP 2013505251 A5 JP2013505251 A5 JP 2013505251A5
Authority
JP
Japan
Prior art keywords
implant
kit
different
implant device
sites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012529897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013505251A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/049104 external-priority patent/WO2011035013A2/en
Publication of JP2013505251A publication Critical patent/JP2013505251A/ja
Publication of JP2013505251A5 publication Critical patent/JP2013505251A5/ja
Pending legal-status Critical Current

Links

JP2012529897A 2009-09-17 2010-09-16 放出プロファイルが異なるインプラントデバイス並びにその製造及び使用方法 Pending JP2013505251A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24330309P 2009-09-17 2009-09-17
US61/243,303 2009-09-17
PCT/US2010/049104 WO2011035013A2 (en) 2009-09-17 2010-09-16 Implant devices that differ by release profile and methods of making and using same

Publications (2)

Publication Number Publication Date
JP2013505251A JP2013505251A (ja) 2013-02-14
JP2013505251A5 true JP2013505251A5 (https=) 2013-11-07

Family

ID=43218276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012529897A Pending JP2013505251A (ja) 2009-09-17 2010-09-16 放出プロファイルが異なるインプラントデバイス並びにその製造及び使用方法

Country Status (10)

Country Link
US (1) US9399018B2 (https=)
EP (1) EP2477612A2 (https=)
JP (1) JP2013505251A (https=)
KR (1) KR20120102598A (https=)
CN (1) CN102917693B (https=)
BR (1) BR112012006103B8 (https=)
CA (1) CA2774495C (https=)
IN (1) IN2012DN02656A (https=)
RU (1) RU2012115120A (https=)
WO (1) WO2011035013A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1781264E (pt) 2004-08-04 2013-10-16 Evonik Corp Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
US20110091518A1 (en) * 2009-09-22 2011-04-21 Danielle Biggs Implant devices having varying bioactive agent loading configurations
WO2018064556A1 (en) 2016-09-29 2018-04-05 Gesea Biosciences Inc. Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
KR102183669B1 (ko) * 2019-03-26 2020-11-26 가톨릭대학교 산학협력단 이중 약물 방출을 위한 약물 전달체
JP6905035B2 (ja) 2019-11-29 2021-07-21 Ｎｉｓｓｈａ株式会社 可食性フィルムの製造方法、フィルム製剤及び可食性フィルム

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309669B1 (en) 1984-03-16 2001-10-30 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
US4720384A (en) 1985-05-03 1988-01-19 E. I. Du Pont De Nemours And Company Manufacture of hollow fine tubular drug delivery systems
US4976949A (en) 1985-10-25 1990-12-11 The University Of Michigan Controlled release dosage form
US4794001A (en) 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
DE3710175A1 (de) 1987-02-12 1988-08-25 Hoechst Ag Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
JPS63203610A (ja) * 1987-02-12 1988-08-23 ヘキスト・アクチエンゲゼルシヤフト 複数成分からなるインプラント用の持効性医薬製剤
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
JP2702729B2 (ja) * 1988-02-24 1998-01-26 エーザイ株式会社 徐放性埋込剤
US5702716A (en) 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5178874A (en) 1989-06-30 1993-01-12 Smithkline Beechman Corporation Intermittent release dosage form
US5153002A (en) 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
JP3118009B2 (ja) 1991-04-16 2000-12-18 住友製薬株式会社 多層構造を有するコラーゲンおよび／またはゼラチン製剤の製造方法
US5876452A (en) 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
US6013853A (en) 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5429822A (en) 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
GB9223144D0 (en) 1992-11-05 1992-12-16 Scherer Corp R P Controlled release device
US5456917A (en) 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
US6447796B1 (en) 1994-05-16 2002-09-10 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
US6855331B2 (en) 1994-05-16 2005-02-15 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US6902743B1 (en) 1995-05-22 2005-06-07 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
US5705191A (en) 1995-08-18 1998-01-06 The United States Of America As Represented By The Secretary Of The Navy Sustained delivery of active compounds from tubules, with rational control
CA2291659A1 (fr) * 1997-06-04 1998-12-10 Debio Recherche Pharmaceutique S.A. Implants pour la liberation controlee de principes pharmaceutiquement actifs et procede pour leur fabrication
CA2301883A1 (en) 1997-09-11 1999-03-18 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
US6296831B1 (en) 1998-04-10 2001-10-02 Battelle Memorial Institute Stimulus sensitive gel with radioisotope and methods of making
AU752225B2 (en) 1998-07-17 2002-09-12 Pacira Pharmaceuticals, Inc. Biodegradable compositions for the controlled release of encapsulated substances
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU6326000A (en) * 1999-07-26 2001-02-13 Bomac Laboratories Limited Improvements in dispensing vaccines
US20020131988A1 (en) 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
CN1404388A (zh) 2000-01-20 2003-03-19 德尔西斯药品公司 多级药物剂型
US6479065B2 (en) 2000-08-10 2002-11-12 Alkermes Controlled Therapeutics, Inc. Process for the preparation of polymer-based sustained release compositions
US20030055075A1 (en) 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
NZ519363A (en) 2002-06-05 2004-02-27 Agres Ltd A novel drug dosing regimen
US7101566B2 (en) 2002-06-28 2006-09-05 Ethicon, Inc. Polymer coated microparticles for sustained release
US7220433B2 (en) 2003-06-27 2007-05-22 Ethicon, Inc. Compositions for parenteral administration and sustained-release of therapeutic agents
US8329203B2 (en) 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8685435B2 (en) * 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
WO2005107715A1 (en) * 2004-05-11 2005-11-17 Debio Recherche Pharmaceutique S.A. Implantable composition
PT1781264E (pt) 2004-08-04 2013-10-16 Evonik Corp Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
EP1835885A1 (en) * 2004-12-23 2007-09-26 Durect Corporation Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of a gnrh
US8969415B2 (en) * 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems

Similar Documents

Publication Publication Date Title
WO2009058990A3 (en) Vascular closure device
BR112012012997A2 (pt) ''microesfera biodegradável, material para utilização em conexão com o tratamento de feridas compreendendo microesferas,curativos de ferida, método para a realização de hemostasia, método para realização do tratamento de uma ferida, método para cultura de células in vitro e método para a realização de embolização vascular"
JP2013505251A5 (https=)
WO2010005723A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
JP2017080618A5 (https=)
WO2012034049A3 (en) Implantable medical devices having double walled microspheres
EP3861982A3 (en) Intracameral implant for treatment of an ocular condition
BRPI0810899A2 (pt) Formulação de nanopartículas de plga ativadas carregadas com agente ativo para substâncias nano-terapêuticas anticâncer direcionais.
BRPI0917390A2 (pt) dispositivo oftálmico tendo capacidade de liberação de agente terapêutico e método de formação do mesmo
CL2013001942A1 (es) Composicion de suministro de farmaco biodegradable que comprende a) un copolimero de tres bloques biodegradable, b) un copolimero de dos bloques biodegradable, y c) cuando menos un principio farmaceuticamente activo; metodo para su preparacion: y su uso.
EP2644114A3 (en) Layered tissue thickness compensator
WO2012166923A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
BRPI0920314A2 (pt) dispositivo médico com liberação controlada de agente antibacteriano
CL2013000677A1 (es) Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn.
BRPI0920824A2 (pt) dispositivos de liberação prolongada de fármaco com polímeros a base de poliuretano e fabricação dos mesmos
NZ601200A (en) Pharmaceutical dosage forms comprising poly(epsilon-caprolactone)
EP1985302A4 (en) DRUGS FOR TUMOR THERAPY AND ITS USE
MX2013012934A (es) Nanoparticulas polimericas para el suministro de farmacos.
EP2383317A4 (en) ALPHA ALLYLOXYMETHYL ACRYLIC ACID BASED COPOLYMER, RESIN COMPOSITION AND USE
EP2231231A4 (en) INTRODUCTION DEVICES, INTRODUCTION NEEDLES AND RELEVANT PROCEDURES
WO2010061288A3 (en) Polymeric pharmaceutical dosage form in sustained release
WO2011080141A3 (en) Degradable removable implant for the sustained release of an active compound
WO2014106116A8 (en) Therapeutic compositions comprising antibodies
AP2010005384A0 (en) Devices for the administration of drugs and vaccines in the form of injectable needles.
ZA200900929B (en) Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same